Vaccine Preventable Diseases: A Public Health Imperative

Vaccine preventable diseases, such as measles, polio, and whooping cough, have been significantly reduced in incidence due to widespread vaccination efforts, with a notable 90% decline in measles-related deaths between 2000 and 2016, according to the World Health Organization (WHO). However, outbreaks still occur, often due to low vaccination rates in certain communities, as seen in the 2019 measles outbreak in the United States, which affected over 1,200 people. The anti-vaccination movement, fueled by misinformation and concerns over vaccine safety, poses a significant threat to public health, with a recent study suggesting that vaccine hesitancy is a major contributor to the resurgence of vaccine preventable diseases. The development of new vaccines, such as those for HPV and Ebola, has also been instrumental in preventing the spread of infectious diseases. As of 2022, the WHO reports that vaccination has saved an estimated 10 million lives between 2010 and 2015, with a projected 25 million lives saved by 2030. Despite these successes, challenges persist, including the need for improved vaccine distribution and access in low-income countries, where vaccine preventable diseases remain a major cause of morbidity and mortality, with a staggering 1.5 million deaths annually, according to the WHO. The future of vaccine development and distribution will be shaped by advances in technology, including the use of mRNA vaccines and artificial intelligence, which are expected to improve vaccine efficacy and accessibility, with a potential 50% reduction in vaccine production costs by 2025.